Somnigroup International Inc. Common Stock vs UBS Group AG Registered Ordinary Shares — how do they compare? Somnigroup International Inc. Common Stock trades at $62.83 (market cap $14.28B), while UBS Group AG Registered Ordinary Shares trades at $47.69 (market cap $145.08B). The key difference: UBS Group AG Registered Ordinary Shares is far larger — about 10.2× Somnigroup International Inc. Common Stock's market cap, and UBS Group AG Registered Ordinary Shares pays the higher dividend (2.33%). Which is the better fit depends on your goals — on Pluang, investors hold Somnigroup International Inc. Common Stock for 0 Days and UBS Group AG Registered Ordinary Shares for 3 Days on average.
| SGI | UBS | |
|---|---|---|
Market Cap | $14.28B | $145.08B |
Volume | 2,254,312 | 1,613,745 |
Sector | Consumer Cyclical | Financials |
52-Week High | $97.99 | $55.72 |
52-Week Low | $61.49 | $36.41 |
Typical Hold Time | 0 Days | 3 Days |
Enterprise Value | $20.58B | $304.42B |
Dividend Yield | 1.1% | 2.33% |
Signals from Pluang's Aura AI — not financial advice
Somnigroup International (SGI) trades at $62.87, up 0.75% with neutral technical signals. The company shows strong profitability with 44.24% gross margins and has beaten earnings estimates for three consecutive quarters. Recent acquisition of Leggett & Platt enhances vertical integration with $75M synergy target. Analyst consensus is strongly bullish with 91% buy ratings and $94.50 price target, representing 50% upside potential from current levels.
SGI presents compelling growth prospects through strategic acquisitions and operational efficiencies, though faces margin pressures in weak bedding markets. The stock trades at reasonable valuations (P/E 24.85) with improving cash flow trends expected in 2026. Key risks include integration execution and market competition, but strong institutional interest and insider buying support the bullish case.
UBS trades at $47.85, showing minimal daily movement with a 0.06% gain. The technical picture is bearish with mixed earnings performance - beating estimates in Q1 2026 but missing in Q4 2025 and Q2 2026. Analyst sentiment leans positive with 55% buy ratings, though the consensus price target of $23.57 sits well below current levels. Recent news highlights UBS's strategic focus on US expansion and ongoing integration challenges.
The outlook remains cautious given the bearish technical signals and valuation concerns. Investment opportunity exists in the company's improving profitability and revenue growth trajectory, but risks include integration challenges from recent acquisitions and exposure to European debt market volatility. The significant gap between current price and analyst targets warrants careful consideration.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Somnigroup International Inc. (formerly Tempur Sealy International) is a bedding and sleep-products company that designs, manufactures, distributes, and retails mattresses and related products. It operates through Tempur Sealy North America, Tempur Sealy International, and Mattress Firm, with brands including Tempur-Pedic, Sealy, Stearns & Foster, and Mattress Firm.
Read more on SGI →UBS is a global financial services company focused on wealth management, investment banking, and asset management. It serves private, corporate, and institutional clients.
Read more on UBS →